NCT05772273 2025-11-21
PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT
The First Affiliated Hospital of Soochow University
Phase NA Recruiting
Clinical Trials
4 trialsNCT06376721 2024-04-19
Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma
Beijing Tongren Hospital
Phase 1/2 Recruiting
NCT04353479 2020-04-20
Combined PD1 Inhibitor and Decitabine in Elderly Patients With Relapse and Refractory Acute Myeloid Leukemia
Shanghai Jiao Tong University School of Medicine
Phase 2 Unknown
NCT02492789 2019-09-30
A Trial to Evaluate Safety and Tolerability of INCSHR01210 in Cancer Patients
Atridia Pty Ltd.
Phase 1 Completed